Search Result "CD11a"
LFA-1 as a Key Regulator of Immune Function: Approaches toward the Development of LFA-1-Based Therapeutics
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 2 Year: 2006 Page: 2771-2795
Author(s): P. A. Giblin, R. M. Lemieux
Characteristics of Natural Killer Cell Interaction with Trophoblast Cells During Pregnancy
Journal: Current Molecular Medicine
Volume: 20 Issue: 3 Year: 2020 Page: 202-219
Author(s): Dmitry Olegovich Bazhenov,Evgeniya Valerevna Khokhlova,Larisa Pavlovna Viazmina,Kseniya Nikolaevna Furaeva,Valentina Anatolievna Mikhailova,Nikolay Anatolievich Kostin,Sergey Alekseevich Selkov,Dmitry Igorevich Sokolov
New Aspects of the Role of LFA-1 in Bacterial Infection
Journal: Current Immunology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 91-100
Author(s): Masashi Emoto
Efalizumab: A Biological Agent for the Treatment of Psoriasis
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 165-168
Author(s): Sarah Hodulik, Suhail Hadi
Recent Developments in Management of Psoriatic Arthritis
Journal: Current Rheumatology Reviews
Volume: 1 Issue: 1 Year: 2005 Page: 9-19
Author(s): Yasser El Miedany
Poly(ADP-Ribosyl)ation Enzyme-1 as a Target for Neuroprotection in Acute Central Nervous System Injury
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2 Issue: 5 Year: 2003 Page: 279-291
Author(s): S. D. Skaper
DNA Methylation in the Pathogenesis of Systemic Lupus Erythematosus
Journal: Current Pharmacogenomics
Volume: 3 Issue: 1 Year: 2005 Page: 73-78
Author(s): Amr H. Sawalha, Bruce Richardson
Leukocyte Function-Associated Antigen-1: Structure, Function and Application Prospects
Journal: Protein & Peptide Letters
Volume: 13 Issue: 4 Year: 2006 Page: 397-400
Author(s): Ma Xingyuan, Zheng Wenyun, Wang Tianwen
Efalizumab
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6 Issue: 3 Year: 2007 Page: 205-210
Author(s): Ekin Savk
Advances in Therapy for Psoriasis: An Overview of Infliximab, Etanercept, Efalizumab, Alefacept, Adalimumab, Tazarotene, and Pimecrolimus
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 273-280
Author(s): Ritu Saini, William D. Tutrone, Jeffrey M. Weinberg